Zhu, L.; Guo, Z.; Zhang, J.; Yang, Y.; Liu, C.; Zhang, L.; Gu, Z.; Li, Y.; Ding, Z.; Shi, G.
Recombinant Human Arresten and Canstatin Inhibit Angiogenic Behaviors of HUVECs via Inhibiting the PI3K/Akt Signaling Pathway. Int. J. Mol. Sci. 2022, 23, 8995.
https://doi.org/10.3390/ijms23168995
AMA Style
Zhu L, Guo Z, Zhang J, Yang Y, Liu C, Zhang L, Gu Z, Li Y, Ding Z, Shi G.
Recombinant Human Arresten and Canstatin Inhibit Angiogenic Behaviors of HUVECs via Inhibiting the PI3K/Akt Signaling Pathway. International Journal of Molecular Sciences. 2022; 23(16):8995.
https://doi.org/10.3390/ijms23168995
Chicago/Turabian Style
Zhu, Lingyu, Zitao Guo, Ji Zhang, Yuliang Yang, Chunyu Liu, Liang Zhang, Zhenghua Gu, Youran Li, Zhongyang Ding, and Guiyang Shi.
2022. "Recombinant Human Arresten and Canstatin Inhibit Angiogenic Behaviors of HUVECs via Inhibiting the PI3K/Akt Signaling Pathway" International Journal of Molecular Sciences 23, no. 16: 8995.
https://doi.org/10.3390/ijms23168995
APA Style
Zhu, L., Guo, Z., Zhang, J., Yang, Y., Liu, C., Zhang, L., Gu, Z., Li, Y., Ding, Z., & Shi, G.
(2022). Recombinant Human Arresten and Canstatin Inhibit Angiogenic Behaviors of HUVECs via Inhibiting the PI3K/Akt Signaling Pathway. International Journal of Molecular Sciences, 23(16), 8995.
https://doi.org/10.3390/ijms23168995
